SEC Filing Summary: PerkinElmer, Inc. (8-K)
Business Context and Reporting Period
This Form 8-K was filed by PerkinElmer, Inc. on September 12, 2014. The report discloses a material corporate event regarding the departure of a senior executive. Note: The input metadata references "REVVITY, INC.", but the filing text explicitly identifies the registrant as PerkinElmer, Inc.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
The primary material change reported is the termination of employment for Daniel R. Marshak, Senior Vice President and Chief Scientific Officer. Dr. Marshak and the Company mutually agreed that his employment would end on September 26, 2014.
Guidance, Outlook, and Risks
The filing does not provide updated financial guidance, outlook, or management commentary regarding future performance. No specific risks or contingencies related to the departure are detailed in this text, other than the loss of the Chief Scientific Officer.
Key Facts for Investor Verification
- Confirm the exact date of Daniel R. Marshak's departure (September 26, 2014).
- Verify if any severance or compensatory arrangements were disclosed in subsequent filings or press releases, as this 8-K does not detail compensation terms.
- Check for announcements regarding the appointment of a successor to the Chief Scientific Officer role.
- Review the company's current corporate name status, as the metadata mentions "REVVITY, INC." while the filing is under "PerkinElmer, Inc."